Investing

Editor's Top Picks

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form Investing

Starbucks CEO says ‘We stand for humanity,’ looks to separate company from Israel-Palestine statements by workers union

The chief executive of Starbucks Corp. thinks the recent spike in vandalism at some of

A Warner Bros.-Paramount merger would create a streaming behemoth. But regulators have shown ‘little appetite for media M&A,’ analyst says.

A merger between entertainment giants Warner Bros. Discovery Inc. and Paramount Global could bring together

Bitcoin Rallies Back to Near Recent Highs as Bullish Crypto Traders Double Down

Bitcoin and other cryptocurrencies gained on Thursday—despite an absence of major crypto catalysts—as traders remained

Job market is softening and bankruptcies are rising, Paychex CEO says

“‘While we haven’t seen any normal signs of a recession in our data, we started

Opinion: These unsung stock market heroes offer 9 favorite picks for 2024

Stock newsletter writers don’t pop up much on CNBC, but that doesn’t mean you should

‘The switch was flipped’: ETF flows pick up as stocks, bonds head for 2023 gains

Hello! Stocks and bonds are heading for gains in 2023 as ETF investors show signs

Elon Musk tells Cathie Wood he wants to create a ‘giant brain’ and financial platform on X

Elon Musk says he hopes to turn X into a “giant brain” and pivot it

Polkadot leads way as most big cryptocurrencies post gains

Most large cryptocurrencies were up during morning trading on Thursday, with Polkadot DOTUSD seeing the

Homes are overvalued in 88% of the U.S., Fitch says

U.S. homes are overvalued in 88% of the nation’s metropolitan areas, according to a new

Nike shares dive after company eyes $2 billion in cost cuts amid ‘softer’ outlook

Shares of Nike Inc. tumbled after hours Thursday after the athletic-gear giant warned of a

Oil futures tally a third straight gain on Red Sea shipping disruptions

Oil futures tallied a third straight climb on Wednesday, buoyed by tensions in the Red

Linamar to Acquire Bourgault Industries For C$640M

By Ben Glickman Linamar will acquire Borgeault Industries for 640 million Canadian dollars ($478.7 million).

FDA Says Merck’s Chronic Cough Treatment Didn’t Show Substantial Evidence of Effectiveness

By Ben Glickman Merck's candidate to treat chronic cough didn't show substantial evidence of effectiveness,

Calliditas Therapeutics Shares Rise 33% After FDA Approves Tarpeyo

By Stephen Nakrosis Shares of Calliditas Therapeutics were topping previous 52-week highs in Wednesday's late-trading

YS Biopharma Says Fake Press Release Called for Extraordinary General Meeting

By Ben Glickman YS Biopharma said a fake press release distributed under the company's name